The SenSzi (GBG80) Trial 1 has assessed the contribution of information derived from lymphoscintigraphy in improving the performance of the sentinel lymph node (SLN) biopsy procedure in cN0 breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results